InMed Pharmaceuticals (INM) Research & Development (2021 - 2025)
Historic Research & Development for InMed Pharmaceuticals (INM) over the last 5 years, with Q4 2025 value amounting to $630636.0.
- InMed Pharmaceuticals' Research & Development fell 2955.17% to $630636.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.2 million, marking a year-over-year decrease of 2323.41%. This contributed to the annual value of $2.9 million for FY2025, which is 1130.05% down from last year.
- As of Q4 2025, InMed Pharmaceuticals' Research & Development stood at $630636.0, which was down 2955.17% from $581612.0 recorded in Q3 2025.
- Over the past 5 years, InMed Pharmaceuticals' Research & Development peaked at $2.5 million during Q4 2021, and registered a low of $112720.0 during Q2 2025.
- Its 5-year average for Research & Development is $1.0 million, with a median of $864829.5 in 2022.
- In the last 5 years, InMed Pharmaceuticals' Research & Development surged by 4680.05% in 2024 and then tumbled by 8289.19% in 2025.
- Quarter analysis of 5 years shows InMed Pharmaceuticals' Research & Development stood at $2.5 million in 2021, then tumbled by 66.44% to $851356.0 in 2022, then fell by 28.37% to $609791.0 in 2023, then soared by 46.8% to $895176.0 in 2024, then fell by 29.55% to $630636.0 in 2025.
- Its Research & Development stands at $630636.0 for Q4 2025, versus $581612.0 for Q3 2025 and $112720.0 for Q2 2025.